ResMed (RMD) Misses Q3 EPS by 1c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $183.78 -0.24%
Revenue Growth %: +4.8%
Financial Fact:
Research and development: 34.45M
Today's EPS Names:
NLY, CP, RUSHA, More
Revenue Growth %: +4.8%
Financial Fact:
Research and development: 34.45M
Today's EPS Names:
NLY, CP, RUSHA, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q3 EPS of $0.68, $0.01 worse than the analyst estimate of $0.69. Revenue for the quarter came in at $453.9 million versus the consensus estimate of $455.88 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ford (F) earnings top estimates in Q1 amid strength in Pro unit; stock up
- SLM (SLM) Tops Q1 EPS by 20c; offers guidance
- VIST Financial Corp. (VIST) Misses Q1 EPS by 19c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
